What is ABBV's health score?

AbbVie Inc. (ABBV) has a TradeApes health score of 46 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ABBV's estimated fair value?

Based on our 5-year discounted cash flow model, AbbVie Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ABBV undervalued or overvalued?

Our model currently rates ABBV as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ABBV... Refresh in a moment for the full analysis.

AbbVie Inc. (ABBV)

Healthcare Overvalued low mixed

$227.23

Updated: 2026-06-06

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

55 Mixed

Relative Value

5 Stressed

Capital Allocation

55 Mixed

Risk

80 Strong

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.